Raquel García‐Hernández

Leishmania donovani Develops Resistance to Drug Combinations

Raquel García‐Hernández, José Ignacio Manzano, Santiago Castanys et al. · PLoS neglected tropical diseases · 2012 · 115 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes

Annelies Mondelaers, María P. Sánchez‐Cañete, Sarah Hendrickx et al. · PLoS ONE · 2016 · 108 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Mapping microglia and astrocyte activation in vivo using diffusion MRI

Raquel García‐Hernández, Antonio Cerdán Cerdá, Alejandro Trouve Carpena et al. · Science Advances · 2022 · 99 citations · Full text

Medicine, Neurobiology, Neuroscience +16

High-Throughput Screening Platform for Natural Product–Based Drug Discovery Against 3 Neglected Tropical Diseases: Human African Trypanosomiasis, Leishmaniasis, and Chagas Disease

Frederick Annang, Guiomar Pérez‐Moreno, Raquel García‐Hernández et al. · SLAS DISCOVERY · 2014 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs

Alberto Rastrojo, Raquel García‐Hernández, Paola Vargas et al. · International Journal for Parasitology Drugs and Drug Resistance · 2018 · 76 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17